Keywords
Abstract
This study focuses on the possible etiopathogenetic mechanisms underlying burning mouth syndrome and the most appropriate clinical management for its treatment. Burning Mouth Syndrome (BMS) is characterized by an intraoral burning sensation or dysesthesia without any detectable alterations in the oral mucosa, causing significant discomfort in affected patients. The idiopathic nature of that type of chronic orofacial pain makes it challenging to identify specific etiopathogenetic factors and mechanisms. Therefore, the therapeutic strategy for BMS is challenging to choose among, including pharmacological approaches involving synthetic drugs or compounds derived from natural substances. The most appropriate clinical management for its treatment may involve different therapeutic approaches, although a definitive protocol for managing BMS has yet to be established.
References
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on Burning Mouth Syndrome: Overview and Patient Management. Crit Rev Oral Biol Med. 2003;14(4):275-91. Doi: 10.1177/154411130301400405.
International Classification of Orofacial Pain, 1st Edition (ICOP). Cephalalgia. 2020 Feb;40(2):129-221. Doi: 10.1177/0333102419893823.
Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The Revised International Association for the Study of Pain Definition of Pain: Concepts, Challenges, and Compromises. Pain. 2020 Sep 1;161(9):1976-1982. Doi: 10.1097/j.Pain.0000000000001939.
Balasubramaniam R, Klasser GD, Delcanho R. Separating Oral Burning from Burning Mouth Syndrome: Unravelling a Diagnostic Enigma. Aust Dent J. 2009 Dec;54(4):293-9. Doi: 10.1111/j.1834-7819.2009.01153.x.
Tan HL, Smith JG, Hoffmann J, Renton T. A Systematic Review of Treatment for Patients with Burning Mouth Syndrome. Cephalalgia. 2022 Feb;42(2):128-161. Doi: 10.1177/03331024211036152.
Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning Mouth Syndrome: A Systematic Review of Treatments. Oral Dis. 2018 Apr;24(3):325-334. Doi: 10.1111/Odi.12660.
Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MDP. The Prevalence of Burning Mouth Syndrome: A Population-Based Study. Br J Dermatol. 2015 Jun;172(6):1654-1656. Doi: 10.1111/Bjd.13613.
Eli I, Baht R, Littner MM, Kleinhauz M. Detection of Psychopathologic Trends in Glossodynia Patients. Psychosom Med. 1994 Sep-Oct;56(5):389-94. Doi: 10.1097/00006842-199409000-00002.
Klein B, Thoppay JR, De Rossi SS, Ciarrocca K. Burning Mouth Syndrome. Dermatol Clin. 2020 Oct;38(4):477-483. Doi: 10.1016/j.Det.2020.05.008.
Fedele S, Fricchione G, Porter SR, Mignogna MD. Burning Mouth Syndrome (Stomatodynia). QJM. 2007 Aug;100(8):527-30. Doi: 10.1093/Qjmed/Hcm049.
Nicoletti M, Neri G, Maccauro G, Tripodi D, Varvara G, Saggini A, Potalivo G, Castellani ML, Fulcheri M, Rosati M, Toniato E, Caraffa A, Antinolfi P, Cerulli G, Pandolfi F, Galzio R, Conti P, Theoharides TC. Impact of Neuropeptide Substance P an Inflammatory Compound on Arachidonic Acid Compound Generation. Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):849-57. Doi: 10.1177/039463201202500403.
Galli F, Lodi G, Sardella A, Vegni E. Role of Psychological Factors in Burning Mouth Syndrome: A Systematic Review and Meta-Analysis. Cephalalgia. 2017 Mar;37(3):265-277. Doi: 10.1177/0333102416646769.
Mendak-Ziółko M, Konopka T, Bogucki ZA. Evaluation of Select Neurophysiological, Clinical and Psychological Tests for Burning Mouth Syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Sep;114(3):325-32. Doi: 10.1016/j.Oooo.2012.04.004.
Schiavone V, Adamo D, Ventrella G, Morlino M, De Notaris EB, Ravel MG, Kusmann F, Piantadosi M, Pollio A, Fortuna G, Mignogna MD. Anxiety, Depression, and Pain in Burning Mouth Syndrome: First Chicken or Egg? Headache. 2012 Jun;52(6):1019-25. Doi: 10.1111/j.1526-4610.2012.02171.x.
Koike K, Shinozaki T, Hara K, Noma N, Okada-Ogawa A, Asano M, Shinoda M, Eliav E, Gracely RH, Iwata K, Imamura Y. Immune and Endocrine Function in Patients with Burning Mouth Syndrome. Clin J Pain. 2014 Feb;30(2):168-73. Doi: 10.1097/AJP.0b013e31828c4bf1.
Shaik Y, Sabatino G, Maccauro G, Varvara G, Murmura G, Saggini A, Rosati M, Conti F, Cianchetti E, Caraffa A, Antinolfi P, Pandolfi F, Potalivo G, Galzio R, Conti P, Theoharides TC. IL-36 Receptor Antagonist with Special Emphasis on IL-38. Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):27-36. Doi: 10.1177/039463201302600103.
Kritas SK, Saggini A, Varvara G, Murmura G, Caraffa A, Antinolfi P, Toniato E, Pantalone A, Neri G, Frydas S, Rosati M, Tei M, Speziali A, Saggini R, Pandolfi F, Theoharides TC, Conti P. Mast Cell Involvement in Rheumatoid Arthritis. J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):655-60.
Boras VV, Brailo V, Lukac J, Kordić D, Blazić-Potocki Z. Salivary Interleukin-6 and Tumor Necrosis Factor-Alpha in Patients with Burning Mouth Syndrome. Oral Dis. 2006 May;12(3):353-5. Doi: 10.1111/j.1601-0825.2005.01209.x.
Ji EH, Diep C, Liu T, Li H, Merrill R, Messadi D, Hu S. Potential Protein Biomarkers for Burning Mouth Syndrome Discovered by Quantitative Proteomics. Mol Pain. 2017 Jan;13:1744806916686796. Doi: 10.1177/1744806916686796.
Bender SD. Burning Mouth Syndrome. Dent Clin North Am. 2018 Oct;62(4):585-596. Doi: 10.1016/j.Cden.2018.05.006.
Lamey PJ. Burning Mouth Syndrome. Dermatol Clin. 1996 Apr;14(2):339-54. Doi: 10.1016/S0733-8635(05)70361-2.
Coculescu EC, Radu A, Coculescu BI. Burning mouth syndrome: a review on diagnosis and treatment. J Med Life. 2014 Oct-Dec;7(4):512-5.
Cho GS, Han MW, Lee B, Roh JL, Choi SH, Cho KJ, Nam SY, Kim SY. Zinc Deficiency May Be a Cause of Burning Mouth Syndrome as Zinc Replacement Therapy Has Therapeutic Effects. J Oral Pathol Med. 2010 Oct;39(9):722-7. Doi: 10.1111/j.1600-0714.2010.00914.x.
Hartrick CT. A Four-Category Verbal Rating Scale (VRS-4), an 11-Point Numeric Rating Scale (NRS-11), and a 100-Mm Visual Analog Scale (VAS) Were Compared in the Assessment of Acute Pain after Oral Surgery. Clin J Pain. 2001 Mar;17(1):104-5. Doi: 10.1097/00002508-200103000-00016.
Egido-Moreno S, Valls-Roca-Umbert J, Perez-Sayans M, Blanco-Carrión A, Jane-Salas E, López-López J. Role of Thyroid Hormones in Burning Mouth Syndrome. Systematic Review. Med Oral Patol Oral Cir Bucal. 2023 Jan 1;28(1):E81-E86. Doi: 10.4317/Medoral.25596.
Talattof Z, Dabbaghmanesh MH, Parvizi Y, Esnaashari N, Azad A. The Association between Burning Mouth Syndrome and Level of Thyroid Hormones in Hashimotos Thyroiditis in Public Hospitals in Shiraz, 2016. J Dent (Shiraz). 2019 Mar;20(1):42-47. Doi: 10.30476/DENTJODS.2019.44562.
Brosvic GM, Doty RL, Rowe MM, Harron A, Kolodiy N. Influences of Hypothyroidism on the Taste Detection Performance of Rats: A Signal Detection Analysis. Behav Neurosci. 1992 Dec;106(6):992-8. Doi: 10.1037//0735-7044.106.6.992.
Traini T, Pettinicchio M, Murmura G, Varvara G, Di Lullo N, Sinjari B, Caputi S. Esthetic Outcome of an Immediately Placed Maxillary Anterior Single-Tooth Implant Restored with a Custom-Made Zirconia-Ceramic Abutment and Crown: A Staged Treatment. Quintessence Int. 2011 Feb;42(2):103-8.
Perinetti G, Caputi S, Varvara G. Risk/Prevention Indicators for the Prevalence of Dental Caries in Schoolchildren: Results from the Italian OHSAR Survey. Caries Res. 2005 Jan-Feb;39(1):9-19. Doi: 10.1159/000081651.
Yamazaki Y, Hata H, Kitamori S, Onodera M, Kitagawa Y. An Open-Label, Noncomparative, Dose Escalation Pilot Study of the Effect of Paroxetine in Treatment of Burning Mouth Syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan;107(1):E6-11. Doi: 10.1016/j.Tripleo.2008.08.024.
Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) for Fibromyalgia. Cochrane Database Syst Rev. 2018 Feb 28;2(2):CD010292. Doi: 10.1002/14651858.CD010292.Pub2.
Tammiala-Salonen T, Forssell H. Trazodone in Burning Mouth Pain: A Placebo-Controlled, Double-Blind Study. J Orofac Pain. 1999 Spring;13(2):83-8.
Fenelon M, Quinque E, Arrive E, Catros S, Fricain JC. Pain-Relieving Effects of Clonazepam and Amitriptyline in Burning Mouth Syndrome: A Retrospective Study. Int J Oral Maxillofac Surg. 2017 Nov;46(11):1505-1511. Doi: 10.1016/j.Ijom.2017.03.032.
Ito M, Kimura H, Yoshida K, Kimura Y, Ozaki N, Kurita K. Effectiveness of Milnacipran for the Treatment of Chronic Pain in the Orofacial Region. Clin Neuropharmacol. 2010 Mar-Apr;33(2):79-83. Doi: 10.1097/WNF.0b013e3181cb5793.
Kato Y, Sato T, Katagiri A, Umezaki Y, Takenoshita M, Yoshikawa T, Sato Y, Toyofuku A. Milnacipran Dose-Effect Study in Patients with Burning Mouth Syndrome. Clin Neuropharmacol. 2011 Jul-Aug;34(4):166-9. Doi: 10.1097/WNF.0b013e318227f100.
Wiffen PJ, Derry S, Bell RF, Rice AS, Tölle TR, Phillips T, Moore RA. Gabapentin for Chronic Neuropathic Pain in Adults. Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD007938. Doi: 10.1002/14651858.CD007938.Pub4.
López-D’alessandro E, Escovich L. Combination of Alpha Lipoic Acid and Gabapentin, Its Efficacy in the Treatment of Burning Mouth Syndrome: A Randomized, Double-Blind, Placebo Controlled Trial. Med Oral Patol Oral Cir Bucal. 2011 Aug 1;16(5):E635-40. Doi: 10.4317/Medoral.16942.
Çınar SL, Kartal D, Pergel T, Borlu M. Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome. Erciyes Med J. 2018;40(1):35-8. Doi: 10.5152/Etd.2018.17160.
Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E. Response to Topical Clonazepam in Patients with Burning Mouth Syndrome: A Clinical Study. Bull Group Int Rech Sci Stomatol Odontol. 2010 May 21;49(1):19-29.
Cui Y, Xu H, Chen FM, Liu JL, Jiang L, Zhou Y, Chen QM. Efficacy Evaluation of Clonazepam for Symptom Remission in Burning Mouth Syndrome: A Meta-Analysis. Oral Dis. 2016 Sep;22(6):503-11. Doi: 10.1111/Odi.12422.
Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A Double-Blind Study on Clonazepam in Patients with Burning Mouth Syndrome. Laryngoscope. 2012 Apr;122(4):813-6. Doi: 10.1002/Lary.22490.
Toida M, Kato K, Makita H, Long NK, Takeda T, Hatakeyama D, Yamashita T, Shibata T. Palliative Effect of Lafutidine on Oral Burning Sensation. J Oral Pathol Med. 2009 Mar;38(3):262-8. Doi: 10.1111/j.1600-0714.2008.00736.x.
Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F. Different Therapeutic Strategies for Burning Mouth Syndrome: Preliminary Data. J Oral Pathol Med. 2010 Sep;39(8):611-6. Doi: 10.1111/j.1600-0714.2010.00922.x.
Silva LA, Siqueira JT, Teixeira MJ, Siqueira SR. The Role of Xerostomia in Burning Mouth Syndrome: A Case-Control Study. Arq Neuropsiquiatr. 2014 Feb;72(2):91-8. Doi: 10.1590/0004-282X20130218.
Frydas S, Varvara G, Murmura G, Saggini A, Caraffa A, Antinolfi P, Tete’ S, Tripodi D, Conti F, Cianchetti E, Toniato E, Rosati M, Speranza L, Pantalone A, Saggini R, Di Tommaso LM, Theoharides TC, Conti P, Pandolfi F. Impact of Capsaicin on Mast Cell Inflammation. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):597-600. Doi: 10.1177/039463201302600303.
Jensen TS, Høye K, Fricová J, Vanelderen P, Ernault E, Siciliano T, Marques S. Tolerability of the Capsaicin 8% Patch Following Pretreatment with Lidocaine or Tramadol in Patients with Peripheral Neuropathic Pain: A Multicentre, Randomized, Assessor-Blinded Study. Eur J Pain. 2014 Oct;18(9):1240-7. Doi: 10.1002/j.1532-2149.2014.00479.x.
Anand P, Bley K. Topical Capsaicin for Pain Management: Therapeutic Potential and Mechanisms of Action of the New High-Concentration Capsaicin 8% Patch. Br J Anaesth. 2011 Oct;107(4):490-502. Doi: 10.1093/Bja/Aer260.
Jääskeläinen SK. Pathophysiology of Primary Burning Mouth Syndrome. Clin Neurophysiol. 2012 Jan;123(1):71-7. Doi: 10.1016/j.Clinph.2011.07.054.
Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic Capsaicin for Burning Mouth Syndrome: Short-Term Results of a Pilot Study. J Oral Pathol Med. 2004 Feb;33(2):111-4. Doi: 10.1111/j.1600-0714.2004.0194n.x.
Müller WE, Rolli M, Schäfer C, Hafner U. Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant Activity. Pharmacopsychiatry. 1997 Sep;30 Suppl 2:102-7. Doi: 10.1055/s-2007-979528.
McCarson KE, Enna SJ. GABA Pharmacology: The Search for Analgesics. Neurochem Res. 2014 Oct;39(10):1948-63. Doi: 10.1007/S11064-014-1254-x.
Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum Perforatum Extract in Burning Mouth Syndrome: A Randomized Placebo-Controlled Study. J Oral Pathol Med. 2008 Aug;37(7):395-401. Doi: 10.1111/j.1600-0714.2008.00663.x.
Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John’s Wort (Hypericum Perforatum): Drug Interactions and Clinical Outcomes. Br J Clin Pharmacol. 2002 Oct;54(4):349-56. Doi: 10.1046/j.1365-2125.2002.01683.x.
Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schütte K, Dyck PJ. Efficacy and Safety of Antioxidant Treatment with α-Lipoic Acid over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 Trial. Diabetes Care. 2011 Sep;34(9):2054-60. Doi: 10.2337/Dc11-0503.
Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning Mouth Syndrome (BMS): Controlled Open Trial of the Efficacy of Alpha-Lipoic Acid (Thioctic Acid) on Symptomatology. Oral Dis. 2000 Sep;6(5):274-7. Doi: 10.1111/j.1601-0825.2000.Tb00138.x.
Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of Efficacy of Alpha-Lipoic Acid in Burning Mouth Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study. Eur J Pain. 2009 May;13(5):492-6. Doi: 10.1016/j.Ejpain.2008.06.004.
Quintão NL, Ferreira J, Beirith A, Campos MM, Calixto JB. Evaluation of the Effects of the Herbal Product Catuama in Inflammatory and Neuropathic Models of Nociception in Rats. Phytomedicine. 2008 Apr;15(4):245-52. Doi: 10.1016/j.Phymed.2007.03.015.
Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an Herbal Compound for Treatment of Burning Mouth Syndrome: Randomized, Controlled, Double-Blind Clinical Trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar;113(3):373-7. Doi: 10.1016/j.Oooo.2011.09.005.
Conti P, Varvara G, Murmura G, Tete S, Sabatino G, Saggini A, Rosati M, Toniato E, Caraffa A, Antinolfi P, Pandolfi F, Potalivo G, Galzio R, Theoharides TC. Comparison of Beneficial Actions of Non-Steroidal Anti-Inflammatory Drugs to Flavonoids. J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):1-7.
Cano-Carrillo P, Pons-Fuster A, López-Jornet P. Efficacy of Lycopene-Enriched Virgin Olive Oil for Treating Burning Mouth Syndrome: A Double-Blind Randomised. J Oral Rehabil. 2014 Apr;41(4):296-305. Doi: 10.1111/Joor.12147.
Shaik-Dasthagirisaheb YB, Varvara G, Murmura G, Saggini A, Caraffa A, Antinolfi P, Tete’ S, Tripodi D, Conti F, Cianchetti E, Toniato E, Rosati M, Speranza L, Pantalone A, Saggini R, Tei M, Speziali A, Conti P, Theoharides TC, Pandolfi F. Role of Vitamins D, E and C in Immunity and Inflammation. J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):291-5.
Zeka, K., Ruparelia, K. C., Arroo, R. R., Bernardi, S., Corradini, V., Pajewski, L. A., Vegliò, F., & Continenza, M. A. (2014). In vitro biocompatibility of a new hydrogel with Crocin, powerful antioxidant found in Crocus Sativus L. flowers. Italian Journal of Anatomy and Embryology, 118(2), 200. Retrieved from https://oajournals.fupress.net/index.php/ijae/article/view/3922.
Paladini A, Fusco M, Cenacchi T, Schievano C, Piroli A, Varrassi G. Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-Analysis. Pain Physician. 2016 Feb;19(2):11-24.
Ottaviani G, Rupel K, Gobbo M, Poropat A, Zoi V, Faraon M, Di Lenarda R, Biasotto M. Efficacy of Ultramicronized Palmitoylethanolamide in Burning Mouth Syndrome-Affected Patients: A Preliminary Randomized Double-Blind Controlled Trial. Clin Oral Investig. 2019 Jun;23(6):2743-2750. Doi: 10.1007/S00784-018-2720-7.
Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic Effects of Melatonin: A Review of Current Evidence from Experimental and Clinical Studies. J Pineal Res. 2011 Oct;51(3):270-7. Doi: 10.1111/j.1600-079X.2011.00895.x.
Varoni EM, Lo Faro AF, Lodi G, Carrassi A, Iriti M, Sardella A. Melatonin Treatment in Patients with Burning Mouth Syndrome: A Triple-Blind, Placebo-Controlled, Crossover Randomized Clinical Trial. J Oral Facial Pain Headache. 2018 Spring;32(2):178-188. Doi: 10.11607/Ofph.1913.
Castillo-Felipe C, Tvarijonaviciute A, López-Arjona M, Pardo-Marin L, Pons-Fuster E, López-Jornet P. Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome. J Clin Med. 2022 Apr 29;11(9):2516. Doi: 10.3390/Jcm11092516.
Bone laser biostimulation applied to implant dentistry: case report. June 2013Clinical Oral Implants Research 24(s8). doi: 10.1111/clr.1218. Conference: Premium Day 2013At: PadovaVolume: Clinical Oral Implants Research 24 (Suppl. 8), 21–22.
Chow RT, Heller GZ, Barnsley L. The Effect of 300 mW, 830 Nm Laser on Chronic Neck Pain: A Double-Blind, Randomized, Placebo-Controlled Study. Pain. 2006 Sep;124(1-2):201-10. Doi: 10.1016/j.Pain.2006.05.018.
Al-Maweri SA, Javed F, Kalakonda B, AlAizari NA, Al-Soneidar W, Al-Akwa A. Efficacy of Low Level Laser Therapy in the Treatment of Burning Mouth Syndrome: A Systematic Review. Photodiagnosis Photodyn Ther. 2017 Mar;17:188-193. Doi: 10.1016/j.Pdpdt.2016.11.017.
Scardina GA, Casella S, Bilello G, Messina P. Photobiomodulation Therapy in the Management of Burning Mouth Syndrome: Morphological Variations in the Capillary Bed. Dent J (Basel). 2020 Sep 1;8(3):99. Doi: 10.3390/Dj8030099.
Spanemberg JC, López López J, de Figueiredo MA, Cherubini K, Salum FG. Efficacy of Low-Level Laser Therapy for the Treatment of Burning Mouth Syndrome: A Randomized, Controlled Trial. J Biomed Opt. 2015 Sep;20(9):098001. Doi: 10.1117/1.JBO.20.9.098001.
De Pedro M, López-Pintor RM, Casañas E, Hernández G. Effects of Photobiomodulation with Low-Level Laser Therapy in Burning Mouth Syndrome: A Randomized Clinical Trial. Oral Dis. 2020 Nov;26(8):1764-1776. Doi: 10.1111/Odi.13443.
Arbabi-Kalati F, Bakhshani NM, Rasti M. Evaluation of the Efficacy of Low-Level Laser in Improving the Symptoms of Burning Mouth Syndrome. J Clin Exp Dent. 2015 Oct 1;7(4):E524-7. Doi: 10.4317/Jced.52298.
Dos Santos Lde F, Carvalho Ade A, Leão JC, Cruz Perez DE, Castro JF. Effect of Low-Level Laser Therapy in the Treatment of Burning Mouth Syndrome: A Case Series. Photomed Laser Surg. 2011 Dec;29(12):793-6. Doi: 10.1089/Pho.2011.3016.
Arduino PG, Cafaro A, Garrone M, Gambino A, Cabras M, Romagnoli E, Broccoletti R. A Randomized Pilot Study to Assess the Safety and the Value of Low-Level Laser Therapy versus Clonazepam in Patients with Burning Mouth Syndrome. Lasers Med Sci. 2016 May;31(4):811-6. Doi: 10.1007/S10103-016-1897-8.
Tan Y, Wu X, Chen J, Kong L, Qian Z. Structural and Functional Connectivity Between the Amygdala and Orbital Frontal Cortex in Burning Mouth Syndrome: An fMRI Study. Front Psychol. 2019 Jul 25;10:1700. Doi: 10.3389/Fpsyg.2019.01700.
Passard A, Attal N, Benadhira R, Brasseur L, Saba G, Sichere P, Perrot S, Januel D, Bouhassira D. Effects of Unilateral Repetitive Transcranial Magnetic Stimulation of the Motor Cortex on Chronic Widespread Pain in Fibromyalgia. Brain. 2007 Oct;130(Pt 10):2661-70. Doi: 10.1093/Brain/Awm189.
Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The Efficacy of Daily Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for Burning Mouth Syndrome (BMS): A Randomized Controlled Single-Blind Study. Brain Stimul. 2016 Mar-Apr;9(2):234-42. Doi: 10.1016/j.Brs.2015.10.005.
Matsuoka H, Chiba I, Sakano Y, Toyofuku A, Abiko Y. Cognitive Behavioral Therapy for Psychosomatic Problems in Dental Settings. Biopsychosoc Med. 2017 Jun 13;11:18. Doi: 10.1186/S13030-017-0102-z.
Bergdahl J, Anneroth G, Perris H. Cognitive Therapy in the Treatment of Patients with Resistant Burning Mouth Syndrome: A Controlled Study. J Oral Pathol Med. 1995 May;24(5):213-5. Doi: 10.1111/j.1600-0714.1995.Tb01169.x.
Miziara ID, Filho BC, Oliveira R, Rodrigues Dos Santos RM. Group Psychotherapy: An Additional Approach to Burning Mouth Syndrome. J Psychosom Res. 2009 Nov;67(5):443-8. Doi: 10.1016/j.Jpsychores.2009.01.013.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Fabiola Rinaldi , Davide Gerardi , Pierangelo Burdo , Francesca Angiolani , Gustavo Durate Mendes , Maurizio Piattelli , Giuseppe Varvara